Development and bioanalytics of therapeutic mAbs and ADC
Description
In this project, monoclonal therapeutic antibodies and antibody-drug conjugates (ADC) are being developed for the treatment of cancer diseases. The aim of the project is the development and optimization of various bioanalytical methods for the physicochemical characterization of the drug substances with further method development for novel targets and the comparative study of lead candidates.
Key Data
Projectlead
Project status
ongoing, started 02/2024
Institute/Centre
Institute of Chemistry and Biotechnology (ICBT)
Funding partner
Third party